Pruritus Pipeline Report, H2 2017 - Therapeutics Review of 25 Companies & Drug Profiles - Research and Markets

The "Pruritus - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Pruritus - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Pruritus (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pruritus (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 4, 12, 6, 1 and 8 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 3 and 1 molecules, respectively.

Pruritus (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

1. Introduction
2. Pruritus - Overview
3. Pruritus - Therapeutics Development
4. Pipeline Overview
5. Pipeline by Companies
6. Pipeline by Universities/Institutes
7. Products under Development by Companies
8. Products under Development by Universities/Institutes
9. Pruritus - Therapeutics Assessment
10. Assessment by Target
11. Assessment by Mechanism of Action
12. Assessment by Route of Administration
13. Assessment by Molecule Type
14. Pruritus - Companies Involved in Therapeutics Development

• Albireo Pharma Inc
• Allergan Plc
• Amorepacific Corp
• Asana BioSciences LLC
• Cara Therapeutics Inc
• Celgene Corp
• Chugai Pharmaceutical Co Ltd
• ELORAC Inc
• GlaxoSmithKline Plc
• Hydra Biosciences Inc
• J Uriach Y Compania SA
• NeuroCycle Therapeutics GmbH
• Patagonia Pharmaceuticals LLC
• Patara Pharma Inc
• Phosphagenics Ltd
• RDD Pharma Ltd
• Sanwa Kagaku Kenkyusho Co Ltd
• Shionogi & Co Ltd
• Sienna Biopharmaceuticals Inc
• Sumitomo Dainippon Pharma Co Ltd
• Teikoku Pharma USA Inc
• Tesaro Inc
• Tioga Pharmaceuticals Inc
• Toray Industries Inc
• Vanda Pharmaceuticals Inc
  

For more information about this report visit https://www.researchandmarkets.com/research/bfhsp9/pruritus

View source version on businesswire.com: http://www.businesswire.com/news/home/20170818005228/en/